Reta, commonly known as Retatrutide, has become one of the most widely discussed research compounds in the peptide space due to its unique triple agonist profile and growing interest among researchers studying metabolic pathways, receptor signaling, and advanced peptide-based research models
Insulin resistance is associated with metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as NAFLD), polycystic ovary syndrome (PCOS), obstructive sleep apnea, and certain metabolic-related conditions
however, recent research suggests that mitochondrial dysfunction (MDF) may contribute to DILI
National Undergraduate Innovation and Entrepreneurship Training Program 2024 (Letter No
Q: What side effects were reported with Retatrutide